Health
First human trial of Oxford coronavirus vaccine shows promise – The Jakarta Post – Jakarta Post
An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
The vaccine, called AZD1222, has been described by the World Health Organization’s chief scientist as the leading candidate in a global race to halt a pandemic that has killed more than 600,000 people.
More than 150 possible vaccines are in various s…
-
General19 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News22 hours agoMore children’s sand products from Kmart and Target recalled over asbestos contamination fears
-
General17 hours agoIslam Makhachev claims UFC welterweight belt with dominant win over Jack Della Maddalena
-
Noosa News23 hours agoBurgess Creek to go weed free